4.8 Editorial Material

Zinc, insulin, and the liver: a menage a trois

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 10, Pages 4136-4139

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI72325

Keywords

-

Ask authors/readers for more resources

Insulin and Zn2+ enjoy a multivalent relationship. Zn2+ binds insulin in pancreatic p cells to form crystalline aggregates in dense core vesicles (DCVs), which are released in response to physiological signals such as increased blood glucose. This transition metal is an essential cofactor in insulin-degrading enzyme and several key Zn2+ finger transcription factors that are required for beta cell development and insulin gene expression. Studies are increasingly revealing that fluctuations in Zn2+ concentration can mediate signaling events, including dynamic roles that extend beyond that of a static structural or catalytic cofactor. In this issue of the fa, Tamaki et al. propose an additional function for Zn2+ in relation to insulin: regulation of insulin clearance from the bloodstream.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available